Phase I trial of gemcitabine (Gemzar), 24 h infusion 5-fluorouracil and folinic acid in patients with inoperable pancreatic cancer.
作者： Helmut Oettle , Uwe Pelzer , Kathrin Mochmuth , Thomas Diebold , Jan Langrehr
DOI: 10.1097/00001813-199909000-00002
关键词:
摘要: Gemcitabine (Gemzar®) has a significant impact upon survival and quality of life for patients with pancreatic cancer, compared with 5-fluorouracil (5-FU). This phase I study was initiated …
lww.com
sci-hub.se 参考文章(0)